Showing results (171-180 of 1,074) with videos related to

Sort By:
Pageof 108
Therapeutic Advances in Neurological Disorders|May 19, 2018
Immunotherapy of experimental and human stroke with agents approved for multiple sclerosis: a systematic reviewMirjam Dreikorn, Zeljko Milacic, Vladimir Pavlovic, et al.
Therapeutic Advances in Neurological Disorders|May 19, 2018
The role of dopaminergic immune cell signalling in poststroke inflammationDaniela Talhada, Monika Rabenstein, Karsten Ruscher
Therapeutic Advances in Neurological Disorders|May 19, 2018
Inflammation in stroke: the role of cholinergic, purinergic and glutamatergic signalingAbraham Martín, María Domercq, Carlos Matute
Therapeutic Advances in Neurological Disorders|August 18, 2018
Long-term evaluation of NEDA-3 status in relapsing-remitting multiple sclerosis patients after switching from natalizumab to fingolimodLara Diem, Krassen Nedeltchev, Timo Kahles, et al.
Therapeutic Advances in Neurological Disorders|August 18, 2018
Can inflammation be resolved in Alzheimer's disease?Mingqin Zhu, Xiuzhe Wang, Li Sun, et al.
Therapeutic Advances in Neurological Disorders|February 16, 2026
Efgartigimod for Guillain-Barré syndrome: a retrospective analysis of efficacy and safetyZhuajin Bi, Xiaodong Ye, Peidong Liu, et al.
Therapeutic Advances in Neurological Disorders|August 30, 2021
Treatment approaches to patients with multiple sclerosis and coexisting autoimmune disordersTobias Brummer, Tobias Ruck, Sven G Meuth, et al.
Therapeutic Advances in Neurological Disorders|February 27, 2023
Longitudinal developmental profile of newborns and toddlers treated for spinal muscular atrophyMagali Ngawa, Fabian Dal Farra, Andrei-Dan Marinescu, et al.
Therapeutic Advances in Neurological Disorders|August 22, 2022
Identification of individuals at risk for postoperative cognitive dysfunction (POCD)Xiao Yang, Xinwei Huang, Min Li, et al.
Pageof 108